Flint J, Harding R M, Boyce A J, Clegg J B
MRC Molecular Haematology Unit, John Radcliffe Hospital, Headington, Oxford, U.K.
Baillieres Clin Haematol. 1993 Mar;6(1):215-62. doi: 10.1016/s0950-3536(05)80071-x.
The haemoglobinopathies are the commonest single gene disorders known, and are so common in some regions of the world that the majority of the population carries at least one genetic abnormality affecting the structure or synthesis of the haemoglobin molecule. The prevalence of the common haemoglobinopathies (the alpha- and beta-thalassaemias, HbS, HbC and HbE) is almost certainly a result of the protection they provide against malaria, as the epidemiological evidence reviewed in this chapter shows. World-wide, the distributions of malaria and the common haemoglobinopathies largely overlap, and micro-epidemiological surveys have confirmed the close relationship between the disorders. However, there are complications to this picture which appear to undermine the malaria hypothesis. First, in some areas, malaria and haemoglobinopathies are not coincident. Second, the malaria hypothesis does not easily explain why no two regions of the world have the same haemoglobinopathy or combination of haemoglobinopathies. The majority of mutations have arisen only once and are regionally specific. By using molecular characterization of mutations and the analysis of haplotypes on haemoglobinopathy-bearing chromosomes it is possible to show how a combination of selection by malaria, genetic drift and population movements can explain the first complication. In order to explain the second, we have argued that malaria selection has operated relatively recently on human populations (within the last 5000 years). The present distribution is then seen as the result of selection elevating sporadic mutations in local populations. In the absence of sufficient gene flow to spread all mutations to all populations, the consequence is a patchwork distribution of haemoglobinopathies. Given time, we would expect the mutations that protect and do not compromise the health of their carriers to become widely disseminated, but it is likely that human intervention will alter this process of natural selection.
血红蛋白病是已知最常见的单基因疾病,在世界某些地区极为普遍,以至于大多数人口至少携带一种影响血红蛋白分子结构或合成的遗传异常。正如本章所综述的流行病学证据所示,常见血红蛋白病(α和β地中海贫血、血红蛋白S、血红蛋白C和血红蛋白E)的流行几乎可以肯定是它们提供了抗疟疾保护的结果。在全球范围内,疟疾和常见血红蛋白病的分布在很大程度上重叠,微观流行病学调查证实了这两种疾病之间的密切关系。然而,这种情况存在一些复杂因素,似乎有损于疟疾假说。首先,在某些地区,疟疾和血红蛋白病并不重合。其次,疟疾假说难以解释为什么世界上没有两个地区具有相同的血红蛋白病或血红蛋白病组合。大多数突变只出现过一次,且具有区域特异性。通过对突变进行分子特征分析以及对携带血红蛋白病的染色体上的单倍型进行分析,可以表明疟疾选择、遗传漂变和人口迁移的综合作用如何解释第一个复杂因素。为了解释第二个因素,我们认为疟疾选择在人类群体中相对较近(在过去5000年内)才起作用。目前的分布情况被视为局部群体中偶发突变被选择提升的结果。由于缺乏足够的基因流动将所有突变传播到所有群体,结果就是血红蛋白病呈现出拼凑式的分布。假以时日,我们预计那些保护携带者且不损害其健康的突变会广泛传播,但人类干预很可能会改变这一自然选择过程。